SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
COVID-19 vaccines
COVID-19 vaccines
Page 24 of 94
Finance
The COVID bump looks over for Pfizer as 2022 forecast falls short of Wall Street estimates, stock drops
By
Riley Griffin
and
Bloomberg
February 8, 2022
Newsletters
Deloitte is expanding its Converge portfolio to serve retail and financial services as well as health
By
David Meyer
and
Alan Murray
February 8, 2022
Health
Pro-vaccine parents are suddenly skeptical when it comes to their young kids getting the jab
By
Sophie Mellor
February 7, 2022
International
Live with COVID or lock down? Omicron is forcing Hong Kong to do a bit of both
By
Grady McGregor
February 7, 2022
Newsletters
Binance CEO Changpeng ‘CZ’ Zhao says regulatory response is a ‘top priority tactical task’ for the crypto exchange
By
David Meyer
and
Alan Murray
February 7, 2022
Politics
Anti-vaxxers block Australia’s capital as Canada’s COVID protest mayhem goes global
By
Ben Westcott
and
Bloomberg
February 7, 2022
Health
Fully vaccinated people are 93% less likely to die of COVID compared to unvaccinated people
By
Tristan Bove
February 4, 2022
Newsletters
Why purpose is such a hot topic in business
By
David Meyer
and
Alan Murray
February 4, 2022
Health
Moderna wouldn’t share its vaccine technology, so South Africa and the WHO made a COVID jab based on it anyway
By
David Meyer
February 4, 2022
International
Novavax’s newest approvals position it as an mRNA ‘alternative’ that health officials say may convince vaccine skeptics
By
Grady McGregor
February 4, 2022
Newsletters
Should natural gas and nuclear play a part in the energy transition?
By
David Meyer
February 3, 2022
Commentary
How George Washington defeated a pandemic to save the American Revolution
By
Willard Sterne Randall
February 2, 2022
Newsletters
Pfizer has become one of the world’s most admired companies
By
David Meyer
and
Alan Murray
February 2, 2022
Well
Brain damage, hair loss, and fatigue: Everything we know about the long-term effects of COVID infections
By
Andrew Marquardt
February 2, 2022
Health
Here’s when to finally expect children under 5 to be eligible for a COVID vaccine
By
Andrew Marquardt
February 1, 2022
Most Popular
Success
Healthcare is the one profession growing right now—and according to OpenAI CEO Sam Altman, it may be the only one...
By
Jessica Coacci
Economy
Congressional Budget Office says Trump's immigration crackdown will shrink U.S. population faster than expected, a...
By
Sasha Rogelberg
Commentary
My wife sold her engagement ring to pay our tax bill. It led to my PhD and my career tackling the student-debt crisis
By
Brian Walsh